Literature DB >> 677864

Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.

K R Ratzan, H B Baker, I Lauredo.   

Abstract

The biliary tract excretion of cefamandole, cefazolin, and cephalothin was measured in eight patients with T-tubes inserted into their common ducts after ductal exploration for biliary tract stones. Each patient received 1.0 g intravenously of each cephalosporin on 3 separate days; T-tube bile and serum were collected at selected time intervals thereafter. In seven patients, bile and urine were collected for 6 h after the administration of each drug. Mean peak levels of cefamandole, cefazolin, and cephalothin in bile were 352, 46, and 12 mug/ml, respectively. The respective mean peak serum levels were 55.0, 92.8, and 32.4 mug/ml. Despite the fact that peak serum levels of cefazolin were 1.5 times those of cefamandole, levels in bile of cefamandole were about 8 times those of cefazolin. Over a 6-h period, almost three times as much cefamandole was excreted into bile as was cefazolin. Therefore, in those patients with biliary tract sepsis, in whom a cephalosporin is indicated for therapy, cefamandole appears to be the drug of choice.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 677864      PMCID: PMC352376          DOI: 10.1128/AAC.13.6.985

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Bacteriologic studies of biliary tract infection.

Authors:  R J Flemma; L M Flint; S Osterhout; W W Shingleton
Journal:  Ann Surg       Date:  1967-10       Impact factor: 12.969

2.  Antibiotic prophylaxis in gastric, biliary and colonic surgery.

Authors:  H H Stone; C A Hooper; L D Kolb; C E Geheber; E J Dawkins
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

3.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

4.  Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.

Authors:  K R Ratzan; C Ruiz; G L Irvin
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

5.  Cephalexin levels in human bile in presence of biliary tract disease.

Authors:  J E Sales; M Sutcliffe; F O'Grady
Journal:  Br Med J       Date:  1972-08-19

6.  Ampicillin levels in human bile in the presence of biliary tract disease.

Authors:  P R Mortimer; D B Mackie; S Haynes
Journal:  Br Med J       Date:  1969-07-12
  6 in total
  13 in total

1.  Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute cholecystitis.

Authors:  R Orda; S A Berger; Y Levy; A Shnaker; A Gorea
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

2.  Penetration of cefazolin, ceftriaxone, cefoperazone, and ceftazidime into human gallbladder tissue and bile.

Authors:  S A Berger; Y Levy; A Halevy; A Gorea; R Orda
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

3.  Biliary excretion of moxalactam.

Authors:  O V Martinez; J U Levi; A Livingstone; T I Malinin; R Zeppa; D Hutson; N Einhorn
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

4.  Pharmacokinetics and clinical study of cefotetan in bile: prophylactic use in biliary tract surgery.

Authors:  P Cherrier; P Perrin; S Gueye; A M Bosio; P Tinel; P Blot; R Richer; F Fauvelle
Journal:  Pharm World Sci       Date:  1993-04-23

5.  Prophylactic and preventive antibiotic therapy: timing, duration and economics.

Authors:  H H Stone; B B Haney; L D Kolb; C E Geheber; C A Hooper
Journal:  Ann Surg       Date:  1979-06       Impact factor: 12.969

6.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  Cefamandole bile levels in patients with hepatobiliary disease.

Authors:  M Uwaydah; H Kantarjian; M Osseiran; F Bal'a
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

8.  Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy.

Authors:  W L Hayton; R Schandlik; K Stoeckel
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Invasion of rabbit ileal tissue by Enterobacter cloacae varies with the concentration of OmpX in the outer membrane.

Authors:  G de Kort; A Bolton; G Martin; J Stephen; J A van de Klundert
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Pharmacokinetics of cefamandole in patients with renal impairment.

Authors:  A W Czerwinski; J A Pederson
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.